PLEASANTON, Calif., May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical ...

For the three and six months ended July 31, 2025 and 2024, management used an estimated annual effective non-GAAP tax rate of 21.0%.

Veeva Systems markets a suite of software services geared toward the biopharmaceutical industry. A wholly owned customer relationship management service is gaining steam for Veeva Systems. With access ...

More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed With a growing number of medical device and diagnostic clinical ...

Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. "We're excited to help Amgen further advance clinical development. Veeva Clinical ...

Veeva Systems, Inc. VEEV reported adjusted earnings per share (EPS) of $1.99 for the second quarter of fiscal 2026, which increased 22.8% from the year-ago figure of $1.62. Adjusted EPS beat the Zacks ...